Searched for
PHARMA LOBBY
If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...- India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRIIndia is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual prop...
- Chinese business hired lobbying firm with ties to Donald Trump Jr, then scored a win in WashingtonA U.S. startup's bid to remove a Chinese investor from its board was rejected by a national security watchdog. A lobbying firm connected to...
- Tariff therapy: Trump nudges pharma cos to make drugs in US or face 100% tariffAmerica is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...
- Painkiller, antibiotic prices set for marginal increase starting April 1Starting April 1, the prices of essential medicines will experience an increase of 0.6%. This change aligns with the annual alterations in ...
- Pharma companies struggle as input costs rise despite 0.6% price hikeFacing a modest 0.6% hike in medicine prices this year, pharmaceutical companies are grappling with the rising costs of raw materials fuele...
- Pharma lobby flags 'cumbersome' export rule, seeks changePharma lobby groups are urging for changes to the centralized no-objection certification (NOC) for drug exports due to a significant export...
- Pharma companies may lose licence if drugs fail testsThe health ministry is considering strict actions, including immediate license suspensions, for drugmakers producing substandard drugs. Thi...
- Indian Pharmaceutical Alliance calls for zero import duty on US drugs to boost local industryThe Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero. Currently, India imp...
- Pharma lobby seeks 2-year extension of schedule M deadlinePharma lobby group FOPE has requested the government to extend the compliance deadline for the revised Schedule M till December 31, 2026. T...
- Pharma lobby, govt meet to discuss OTC drug regulationThe drug regulator had earlier this year formed an expert panel to evaluate medicines which can become OTC from prescription after pharmace...
- India's pharma lobby bats for drug approvals in line with global marketsAccording to the OPPI, launching a new drug in India is delayed by up to four years, compared to markets like the US and the European Union...
- Pharma companies ask government to exempt cheap drugs from price controlThe pharmaceutical industry has sought an exemption from ceiling price for all low-priced formulations up to Rs 5 per unit. In a meeting he...
- Pharma sector marketing practices under government scannerA high-level committee formed under Niti Aayog's VK Paul held a meeting on Friday with the representatives of pharma lobby groups to review...
- Panel for removing penal provisions from proposed Drugs Act for lapsesThe existing Drugs and Cosmetics Act, 1940 is prosecutable. Any drug/cosmetic deemed to be adulterated or spurious is punishable with impri...
- Pharma lobby group backs granting of voluntary licenses by patent holders to Indian companies"Simple waiving of patents for vaccines is not enough for increased and free availability of Vaccines in India,” it said in a statement.The...
- Pharma lobby cries foul on GIPC’s poor ranking to IndiaGlobal Intellectual Property Centre (GIPC) index on intellectual property (IP) standards once again places India at the bottom of 45 countr...
- Telangana to lobby for pharma industry with CentreTelangana industries minister KT Rama Rao pointed out that the pharma industry’s growth rate fell to 5.5% in the past two years while the c...
- RIL, Nasscom, Sun Pharma & Orchid paid Rs 1.4 cr for lobbying in USReliance Industries, Nasscom, Sun Pharma and Orchid Chemicals -- have together paid close to $2,75,000 (about Rs 1.4 crore) towards lobbyin...
- Pharma companies caught in Jammu-Srinagar crossfireSrinagar and Jammu are bracing for another crisis, this time for medicine.
Load More
